Render Target: SSR
Render Timestamp: 2024-11-17T16:20:30.170Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-20 06:19:03.963
Product last modified at: 2024-05-30T07:02:51.064Z
1% for the planet logo
PDP - Template Name: Growth Factors and Cytokines
PDP - Template ID: *******9ad1159

Human Leukemia Inhibitory Factor (hLIF) #8911

We recommend the following alternatives

Inquiry Info. # 8911

Please see our recommended alternatives.

    Product Information

    Formulation

    With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hLIF. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.

    Storage

    Stable in lyophilized state at -20°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months and at -20°C for 6 months. Avoid repeated freeze-thaw cycles.
    Maintain sterility. Storage at -20°C should be in a manual defrost freezer.

    Product Description

    MW (kDa) 20
    Purity >98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hLIF. All lots are greater than 98% pure.
    Endotoxin Less than 0.01 ng endotoxin/1 μg hLIF.
    Activity The bioactivity of recombinant hLIF was determined in a TF-1 cell proliferation assay. The ED50 of each lot is between 0.2-1.5 ng/ml.
    Molecular Formula Based on amino acid sequencing, greater than 30% of recombinant hLIF has a Met on the amino-terminal Ser23 (MSPLP) and has a calculated MW of 19,847. The remainder starts at Ser23 (SPLPI), Pro24 (PLPIT), or Pro26 (PITPV). DTT-reduced protein migrates as a 20 kDa polypeptide and non-reduced protein migrates as a 17 kDa polypeptide due to intramolecular cystines.

    Source / Purification

    Recombinant human LIF (hLIF) Ser23-Phe202 (Accession #P15018) was produced in E. coli at Cell Signaling Technology.

    Background

    Leukemia Inhibitory Factor (LIF) is a 20 kDa pleiotrophic factor belonging to the IL-6 superfamily of cytokines (1). LIF is expressed in a number of tissues and cell types. The LIF receptor is a heterodimer comprised of LIF-R (gp190) and gp130, a common signal transducer for IL-6-type cytokines (1). Depending on cell type and context, LIF/LIF-R can activate Erk, PI3K, and Jak1/Stat1/3 pathways (1,2). LIF has a diverse array of biological activities. Murine embryonic stem cells are dependent on LIF for pluripotency and self-renewal in vitro (1). Exercise- induced LIF secretion in muscle induces myoblast proliferation, suggesting that LIF may play a role in exercise-induced muscle hypertrophy (2). LIF also negatively regulates Th2 and Th17 cell differentiation (3,4).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.